James Kihara, Principal Accounting Officer at ACADIA PHARMACEUTICALS INC (ACAD), sold 2,000 shares at $25.88 ($52K) on 2023-09-15, disclosed to the SEC on 2023-09-19.
Scheduled sale ($52k) by Principal Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |